Ticker: MTNB

Matinas BioPharma Holdings, Inc. (NYSE: MTNB) recently released its quarterly financial results for the period ending March 31, 2025. The company is navigating through critical financial conditions as it continues its focus on advancing its lipid nanocrystal (LNC) platform delivery technology. Be...